Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

Phase 1 Not yet recruiting 40 enrolled 35Pharma Inc

RandomizedSequentialQuadruple-blindTreatment

Summary

Study of HS235 in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction Utilizing Ambulatory Pulmonary Artery Pressure Monitoring

Timeline

Start: 2025-09
Primary completion: 2027-09
Completion: 2028-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HS235	Unknown	—	Subcutaneous

Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

Summary

Timeline

Drugs

Indications